Abdi İbrahim İlaç Executive and Leadership Team

Süha Taşpolatoğlu, the Chief Executive Officer at Abdi İbrahim İlaç, directs the overarching corporate strategy and long-term vision for the organization. Overseeing the expansion of pharmaceutical services across international markets, the Chief Executive Officer ensures that the company maintains a competitive edge in the healthcare sector. This leadership role involves constant collaboration with the Board to align operational goals with the mission of improving public health outcomes. By optimizing internal processes and fostering a culture of innovation, Süha Taşpolatoğlu drives the company toward sustainable growth and market leadership. The Chief Executive Officer monitors global industry trends to identify new opportunities for product development and strategic partnerships. Through rigorous oversight of all business units, the Chief Executive Officer guarantees that the organization remains a pillar of reliability and quality in the pharmaceutical industry, consistently delivering value to patients and stakeholders alike.

Mazhar Çavdar, the Chief Financial Officer, Country at Abdi İbrahim İlaç, manages the fiscal health and economic stability of the organization. Overseeing capital allocation and financial reporting, the Chief Financial Officer, Country ensures that all budgetary requirements support the company's pharmaceutical manufacturing objectives. This role involves analyzing market data to mitigate financial risks while maximizing profitability across regional operations. By implementing robust financial controls, Mazhar Çavdar maintains the integrity of the company's balance sheet and supports long-term investment strategies. The Chief Financial Officer, Country coordinates with other executive leaders to ensure that resource distribution aligns with the strategic goals of the firm. Through precise financial planning and performance monitoring, the Chief Financial Officer, Country secures the necessary funding for research and development initiatives, ultimately strengthening the market position of the company within the competitive healthcare landscape.

Gülçin Oğuz, the Chief Financial Officer Asistanı at Abdi İbrahim İlaç, facilitates the operational efficiency of the finance department by coordinating complex administrative and analytical tasks. Overseeing the flow of financial documentation and supporting the executive team in data-driven decision-making, the Chief Financial Officer Asistanı ensures that fiscal processes remain streamlined and accurate. This role involves managing internal communications regarding budgetary updates and assisting in the preparation of comprehensive financial reports. By maintaining meticulous records and organizing critical meetings, Gülçin Oğuz enables the finance leadership to focus on high-level strategic planning. The Chief Financial Officer Asistanı acts as a vital link between various departments, ensuring that financial policies are communicated effectively throughout the organization. Through diligent support and process optimization, the Chief Financial Officer Asistanı contributes to the overall stability and administrative excellence of the company's financial operations.

Aydin Ozuer, the President & Biotechnology, Abdibio Executive Board Member at Abdi İbrahim İlaç, leads the advancement of cutting-edge biotechnological research and development. Overseeing the integration of advanced scientific methodologies into the company's product pipeline, the President & Biotechnology, Abdibio Executive Board Member ensures that the firm remains at the forefront of medical innovation. This role involves directing the strategic direction of the biotechnology division and collaborating with the Board to prioritize high-impact projects. By fostering partnerships with research institutions, Aydin Ozuer accelerates the transition from laboratory discovery to market-ready pharmaceutical solutions. The President & Biotechnology, Abdibio Executive Board Member monitors the efficacy of new treatments to ensure compliance with international health standards. Through visionary leadership in the biotech space, the President & Biotechnology, Abdibio Executive Board Member drives the company's mission to provide life-enhancing therapies to patients worldwide.

M. Oğuzcan, the President, Human Resources, Communications & Sustainability at Abdi İbrahim İlaç, directs the development of the company's workforce and corporate reputation. Overseeing talent acquisition, internal communications, and environmental sustainability initiatives, the President, Human Resources, Communications & Sustainability ensures that the organizational culture aligns with the company's core values. This role involves implementing programs that promote employee engagement and professional growth while managing the public image of the firm. By integrating sustainable practices into daily operations, M. Oğuzcan reduces the environmental footprint of the pharmaceutical manufacturing process. The President, Human Resources, Communications & Sustainability coordinates with other executives to ensure that corporate social responsibility remains a central pillar of the business strategy. Through effective leadership in human capital and communications, the President, Human Resources, Communications & Sustainability fosters a resilient and purpose-driven organization that attracts top talent and maintains public trust.